Evidence map›Paper›PMID 41531166›Full record

ArticleBiotechnology progress

Dynamics of natural killer cell function upon recurrent stimulation.

Jennifer One, Janani Narayan, Frank Cichocki, Wei-Shou Hu, Samira M Azarin

Abstract read
In one paragraph

Article in Biotechnology progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer OneDepartment of Biomedical Engineering, University of Minnesota, Minneapolis, Minnesota, USA.
Janani NarayanDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Frank CichockiDepartment of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Wei-Shou HuDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.
Samira M AzarinDepartment of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota, USA.ORCID 0000-0003-0395-4988

Funding

Bcl11b: A Master Transcription Factor Controlling Human NK Cell DevelopmentR01HL155150 · NHLBI · UNIVERSITY OF MINNESOTA · PI CICHOCKI, FRANK · 2021 to 2025
$1.6M
National Science Foundation CBET-1845366NHLBI NIH HHS R01 HL155150NIH HHS R01 HL155150
6 · The paper itself

Abstract

Natural killer (NK) cells have shown potential for allogeneic cell-based cancer immunotherapies. For development of economical off-the-shelf allogeneic therapies, maximal expansion of the NK cells from each donor must be achieved while maintaining efficacy and uniformity of the cell product. The standard method for robust expansion utilizes weekly stimulation with engineered feeder cells derived from the K562 cell line. However, the effects of repeated stimulation on NK cell growth, metabolism, and function are not well understood. In this study, we demonstrated a distinct shift in growth kinetics and metabolism around week 3-4 of repeated K562 feeder cell stimulation, followed by a change in cytokine secretion and killing ability. Seahorse metabolic flux assays and transcriptomics suggested a transition from glycolytic metabolism to oxidative metabolism after the first week of stimulation, but the shift in growth kinetics generally correlated to reduced metabolic activity. Collectively, these results indicate that serial stimulation sustains large-fold NK cell expansion that can be exploited for NK cell therapy; however, this expansion has important impacts on NK cell growth, metabolism, and function. Careful characterization is critical when developing large-scale biomanufacturing processes to ensure efficacy of the final cellular product.

Indexed as

Cell Culture TechniquesKiller Cells, NaturalCell ProliferationCytokinesFeeder CellsGene Expression ProfilingHumansK562 CellsMetabolic Flux AnalysisCytokinesbiomanufacturingcytotoxicitygrowthmetabolismnatural killer cells

Identifiers

PMID41531166
PMCPMC13055136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.